Evaluation of hemolysis index thresholds in selected biochemistry measurands

Evaluation of hemolysis index thresholds in selected biochemistry measurands - HIL-CHECK

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00030031

Enrollment

240

Registered

2023-03-22

Start date

2023-04-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

in-vitro hemolysis

Interventions

Group 1: Voluntary participants m/f between 18-99 years. Approximately 40 ml of blood (20 ml serum and 20 ml lithium-heparin blood) is taken from the participants. Dilution series with previously defi

Eligibility

Sex/Gender

All

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: none

Exclusion criteria

Exclusion criteria: Missing declaration of consent illiteracy Inability to use the German language Lack of compliance Abort at own request without giving reasons

Design outcomes

Primary

Measure	Time frame
Measurement of all produced dilution series on different laboratory machines	—

Secondary

Measure	Time frame
Additional data analysis with regard to age, gender and sample material (serum, lithium-heparin plasma)	—

Countries

Germany

Contacts

Public ContactAstrid Petersmann

Universitätsinstitut für Klinische Chemie und Laboratoriumsmedizin Klinikum Oldenburg AöR

zentrallabor@klinikum-oldenburg.de+49 441 403 2601

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026